Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide-based regimens for H. pylori in children
NCT04415983Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Jun 2020
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in Helicobacter pylori infection, sponsored by Tanta University. Started Jun 2020; status: recruiting.
02
Drugs
nitazoxanide
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04415983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415983.